Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Frenova Renal Research Retains SCORR Marketing | Contract Pharma
Breaking News

Frenova Renal Research Retains SCORR Marketing

To develop strategies to support Frenova’s dedication to renal research

Frenova Renal Research has named SCORR Marketing, a marketing communications company focused on drug and device development services, as its agency.
 
Frenova, formerly the Clinical Studies Group of Fresenius Medical Care North America, is a Phase I-IV drug and device clinical development services company dedicated exclusively to renal research. Frenova’s goal is to provide an intimate understanding of patients affected by kidney disease and to improve the quality of life for people with renal impairment.
 
“As the industry’s only dedicated renal CRO, Frenova Renal Research is providing something that other CROs can’t,” said Cinda Orr, president and chief executive officer of SCORR Marketing. “We helped Frenova unveil its new name and brand identity at the recent Partnerships in Clinical Trials 2014 and are excited to develop strategies that will effectively support Frenova’s mission of improving the lives of those affected by a renal impairment.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters